查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1381154

肺炎检测​​市场：按类型、方法、技术和最终用户划分 - 2023-2030 年全球预测

Pneumonia Testing Market by Type (Instruments, Reagents & Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology, End-user - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

肺炎检测​​市场预计将从 2022 年的 14.1 亿美元增加到 2030 年的 22.8 亿美元，预测期内年复合成长率为 6.17%。

全球肺炎检测市场

主要市场统计
市场金额：基准年 [2022] 14.1亿美元
预计市场金额[2023] 14.9亿美元
预计市场金额[2030] 22.8亿美元
年复合成长率（%） 6.17%
肺炎测试市场-IMG1

FPNV定位矩阵

FPNV定位矩阵是评估肺炎检测市场的必备工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1.肺炎检测市场规模及预测是多少？

2. 肺炎检测市场中哪些产品、细分市场、应用和领域具有最高的投资潜力？

3.肺炎检测市场竞争策略的窗口是什么？

4.肺炎检测市场的最新技术趋势和法律规范是什么？

5.肺炎检测市场主要厂商的市场占有率是多少？

6.进入肺炎检测市场合适的型态与策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 随着世界老年人口的增加，肺炎的盛行率也增加
      • 医疗机构采取配合措施提高对肺炎的认识
      • 人们对肺炎即时检测 (POCT) 的兴趣日益浓厚
    • 抑制因素
      • 肺炎综合检测费用高
    • 机会
      • 加强先进、快速、准确的肺炎诊断检测的开发
      • 扩大基于生物标记的创新测试的可能性
    • 任务
      • 在资源有限的环境中进行测试的机会有限
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章肺炎检测市场：依类型

  • 装置
  • 试剂及消耗品

第7章肺炎检测市场：依方法分类

  • 免疫诊断
  • 分子诊断
  • 即时检测

第8章肺炎检测市场：依技术分类

  • 酵素免疫分析法
  • 萤光
  • 免疫组织化学
  • 聚合酶炼式反应
  • 蛋白质印迹

第9章肺炎检测市场：依最终用户分类

  • 诊断实验室
  • 医院和诊所

第10章美洲肺炎检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太肺炎检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲肺炎检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Curetis GmbH
    • Danaher Corporation
    • DiaSorin SpA
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd
    • Hain Lifescience GmbH by Bruker Corporation
    • Hologic, Inc.
    • Intec Products, Inc.
    • Luminex Corporation
    • Meridian Bioscience, Inc.
    • OpGen Inc.
    • QIAGEN NV
    • Quest Diagnostics Incorporated
    • Quidel Corporation
    • Sekisui Diagnostics, LLC
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Trinity Biotech PLC
    • True Bearing Diagnostics, Inc.
  • 主要产品系列

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-69324464D11E

The Pneumonia Testing Market is projected to reach USD 2.28 billion by 2030 from USD 1.41 billion in 2022, at a CAGR of 6.17% during the forecast period.

Global Pneumonia Testing Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 1.41 billion
Estimated Year Value [2023] USD 1.49 billion
Forecast Year Value [2030] USD 2.28 billion
CAGR (%) 6.17%
Pneumonia Testing Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pneumonia Testing Market.

Based on Type, market is studied across Instruments and Reagents & Consumables. The Instruments is projected to witness significant market share during forecast period.

Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing. The Point of Care Testing is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Polymerase Chain Reaction, and Western Blot. The Immunohistochemistry is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Diagnostic Laboratories and Hospitals & Clinics. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pneumonia Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pneumonia Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pneumonia Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Curetis GmbH, Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hain Lifescience GmbH by Bruker Corporation, Hologic, Inc., Intec Products, Inc., Luminex Corporation, Meridian Bioscience, Inc., OpGen Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and True Bearing Diagnostics, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Pneumonia Testing Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Pneumonia Testing Market?

3. What is the competitive strategic window for identifying opportunities in the Pneumonia Testing Market?

4. What are the latest technology trends and regulatory frameworks in the Pneumonia Testing Market?

5. What is the market share of the leading vendors in the Pneumonia Testing Market?

6. Which modes and strategic moves are suitable for entering the Pneumonia Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Pneumonia Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of pneumonia with expanding geriatric population worldwide
      • 5.1.1.2. Availability of initiatives by healthcare organizations to raise awareness about pneumonia
      • 5.1.1.3. Growing inclination towards point-of-care testing (POCT) for pneumonia
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of comprehensive pneumonia testing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
      • 5.1.3.2. Expanding potential for innovative biomarker-based tests
    • 5.1.4. Challenges
      • 5.1.4.1. Limited access to testing in resource-limited settings
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Pneumonia Testing Market, by Type

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Consumables

7. Pneumonia Testing Market, by Method

  • 7.1. Introduction
  • 7.2. Immunodiagnostics
  • 7.3. Molecular Diagnostics
  • 7.4. Point of Care Testing

8. Pneumonia Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Enzyme Linked Immunosorbent Assay
  • 8.3. Immunofluorescence
  • 8.4. Immunohistochemistry
  • 8.5. Polymerase Chain Reaction
  • 8.6. Western Blot

9. Pneumonia Testing Market, by End-user

  • 9.1. Introduction
  • 9.2. Diagnostic Laboratories
  • 9.3. Hospitals & Clinics

10. Americas Pneumonia Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Pneumonia Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Pneumonia Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Becton, Dickinson and Company
    • 14.1.3. Bio-Rad Laboratories, Inc.
    • 14.1.4. bioMerieux SA
    • 14.1.5. Curetis GmbH
    • 14.1.6. Danaher Corporation
    • 14.1.7. DiaSorin S.p.A.
    • 14.1.8. Eurofins Scientific SE
    • 14.1.9. F. Hoffmann-La Roche Ltd
    • 14.1.10. Hain Lifescience GmbH by Bruker Corporation
    • 14.1.11. Hologic, Inc.
    • 14.1.12. Intec Products, Inc.
    • 14.1.13. Luminex Corporation
    • 14.1.14. Meridian Bioscience, Inc.
    • 14.1.15. OpGen Inc.
    • 14.1.16. QIAGEN N.V.
    • 14.1.17. Quest Diagnostics Incorporated
    • 14.1.18. Quidel Corporation
    • 14.1.19. Sekisui Diagnostics, LLC
    • 14.1.20. Siemens Healthineers AG
    • 14.1.21. Thermo Fisher Scientific Inc.
    • 14.1.22. Trinity Biotech PLC
    • 14.1.23. True Bearing Diagnostics, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PNEUMONIA TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. PNEUMONIA TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PNEUMONIA TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. PNEUMONIA TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. PNEUMONIA TESTING MARKET DYNAMICS
  • FIGURE 7. PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
  • FIGURE 8. PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2022 VS 2030 (%)
  • FIGURE 10. PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 12. PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PNEUMONIA TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PNEUMONIA TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PNEUMONIA TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PNEUMONIA TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PNEUMONIA TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 9. PNEUMONIA TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PNEUMONIA TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PNEUMONIA TESTING MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. PNEUMONIA TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PNEUMONIA TESTING MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. PNEUMONIA TESTING MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PNEUMONIA TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PNEUMONIA TESTING MARKET SIZE, BY WESTERN BLOT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. PNEUMONIA TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. PNEUMONIA TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES PNEUMONIA TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA PNEUMONIA TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM PNEUMONIA TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. PNEUMONIA TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. PNEUMONIA TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. PNEUMONIA TESTING MARKET LICENSE & PRICING